Behavioral effects of a neurotoxic compound isolated from Clibadium surinamense L (Asteraceae)

被引:8
作者
Costa, Elson A.
Rocha, Fabio F.
Torres, Maria Luce B.
Souccar, Caden
De Lima, Thereza C. M.
Lapa, Antonio J.
Lima-Landman, Maria Teresa R.
机构
[1] Univ Fed Sao Paulo, EPM, Nat Prod Sect, Dept Pharmacol, BR-04044020 Sao Paulo, Brazil
[2] Univ Fed Santa Catarina, Dept Farmacol, Florianopolis, SC, Brazil
[3] Univ Fed Goias, Dept Ciencias Fisiol, Inst Ciencias Biol, Goiania, Go, Brazil
[4] Ctr Univ Barra Mansa, Barra Mansa, RJ, Brazil
关键词
Clibadium surinamense L; seizures; ichthyotoxic activity; cunaniol acetate;
D O I
10.1016/j.ntt.2006.01.010
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Clibadium surinamense L, popularly known as cunambi, is a native plant from the Northern region of Brazil illegally used for predatory fishing. Previous results from our laboratory have demonstrated that the oral treatment of mice with the ethanolic extract (EE) of the leaves of the plant induced generalized tonic-clonic seizures followed by death within 30 min. The aims of the present paper were to characterize the convulsant effect of the hexanic extract (HE) of the stems and leaves of C surinamense and, by bioguided purification, to identify the active principle and its mechanism of action. The leaves and stems were extracted with hexane (100 g/L) in Soxhlet for 36h (yield of 2.4%), the solvent was evaporated and the powder dissolved in 1.5% saline/Tween 80. Male mice (30-35g) treated with HE (22.5-360 mg/kg, p.o.) showed behavioral alterations consistent with CNS stimulation. The intensity and duration of the effect were proportional to the administered doses. The behavioral alterations, measured with a graded score of seizure severity, revealed that pretreatment with carbamazepine (30 mg/kg, i.p., 60 min) or phenytoin (50 mg/kg, i.p., 30 min) did not alter the HE convulsive effect. In contrast, phenobarbital (30 mg/kg, i.p., 60 min) or diazepam (2 mg/kg, i.p., 30 min) reduced the HE effect, increasing the ED50 for clonic seizures from 64.4 to 89.8 mg/kg and 168.9 mg/kg, respectively. Purification of the HE in a silica gel column eluted with a hexane/ethyl acetate gradient yielded a single fraction with convulsant effect in which cunaniol acetate was identified by H-1 NMR as the main active compound. These results indicated that inhibition of GABAergic transmission by cunaniol acetate might be responsible for the convulsant effects of C. surinamense L in mice, but do not exclude a direct cunaniol action labilizing neuronal excitability. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:349 / 353
页数:5
相关论文
共 20 条
[1]
Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024 [J].
Ambrósio, AF ;
Soares-da-Silva, P ;
Carvalho, CM ;
Carvalho, AP .
NEUROCHEMICAL RESEARCH, 2002, 27 (1-2) :121-130
[2]
Convulsant activity and neurochemical alterations induced by a fraction obtained from fruit Averrhoa carambola (Oxalidaceae: Geraniales) [J].
Carolino, ROG ;
Beleboni, RO ;
Pizzo, AB ;
Del Vecchio, F ;
Garcia-Cairasco, N ;
Moyses-Neto, M ;
dos Santos, WF ;
Coutinho-Netto, J .
NEUROCHEMISTRY INTERNATIONAL, 2005, 46 (07) :523-531
[3]
ICHTHYOTHEREOL AND ITS ACETATE ACTIVE POLYACETYLENE CONSTITUENTS OF ICHTHYOTHERE TERMINALIS (SPRENG) MALME A FISH POISON FROM LOWER AMAZON [J].
CASCON, SC ;
MORS, WB ;
TURSCH, BM ;
APLIN, RT ;
DURHAM, LJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1965, 87 (22) :5237-&
[4]
Mechanisms of action of antiepileptic drugs [J].
Czapinski, P ;
Blaszczyk, B ;
Czuczwar, SJ .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (01) :3-14
[5]
EFFECT OF MORPHINE AND MORPHINE-LIKE ANALGESICS ON SUSCEPTIBILITY TO SEIZURES IN MICE [J].
CZUCZWAR, SJ ;
FREY, HH .
NEUROPHARMACOLOGY, 1986, 25 (05) :465-469
[6]
Ricinine-elicited seizures: A novel chemical model of convulsive seizures [J].
Ferraz, AC ;
Pereira, LF ;
Ribeiro, RL ;
Wolfman, C ;
Medina, JH ;
Scorza, FA ;
Santos, NF ;
Cavalheiro, EA ;
Da Cunha, C .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 65 (04) :577-583
[7]
Fischer W, 2004, BASIC CLIN PHARMACOL, V94, P79, DOI 10.1111/j.1742-7843.2004.pto940205.x
[8]
FRENANDES MJS, 1996, NEUROCHEM, V5, P497
[9]
GOLENDA A M, 1978, Byulleten' Eksperimental'noi Biologii i Meditsiny, V86, P139
[10]
GORINSKY C, 1973, J NAT PRODUCTS, V36, P217